Literature DB >> 14979967

Third and fourth branchial pouch anomalies.

P A Rea1, B E J Hartley, C M Bailey.   

Abstract

Congenital sinuses arising from the pyriform fossae are rare. They may present as neck cysts, recurrent neck abscesses, thyroiditis or neonatal stridor. Children typically undergo multiple surgical procedures before the diagnosis is made. We present our recent experience of five third-pouch sinuses and four fourth-pouch sinuses, including one bilateral case. The median age at presentation was four years. The mean number of operations prior to diagnosis was six (range 0-13), with a mean delay to diagnosis of six years. The diagnosis was made by barium swallow, by ultrasound, at pharyngoscopy or at open surgery. The median age at definitive surgery was 10 years. Definitive treatment involved complete excision of the sinus and neck mass in seven cases. Two sinuses were treated with endoscopic diathermy to their internal opening. Adoption of the correct nomenclature, diagnostic tools and operative requirements for these cases will help reduce the significant morbidity.

Entities:  

Mesh:

Year:  2004        PMID: 14979967     DOI: 10.1258/002221504322731574

Source DB:  PubMed          Journal:  J Laryngol Otol        ISSN: 0022-2151            Impact factor:   1.469


  3 in total

1.  Differences in the characteristics and management of pyriform sinus fistula between neonates and young children.

Authors:  Hizuru Amano; Hiroo Uchida; Kaori Sato; Hiroshi Kawashima; Yujiro Tanaka; Shinya Takazawa; Takahiro Jimbo
Journal:  Pediatr Surg Int       Date:  2012-01       Impact factor: 1.827

2.  A third branchial pouch cyst presenting as stridor in a child.

Authors:  Joseph Wasson; Sean Blaney; Ricard Simo
Journal:  Ann R Coll Surg Engl       Date:  2007-01       Impact factor: 1.891

3.  Revisiting imaging features and the embryologic basis of third and fourth branchial anomalies.

Authors:  B Thomas; M Shroff; V Forte; S Blaser; A James
Journal:  AJNR Am J Neuroradiol       Date:  2009-12-10       Impact factor: 3.825

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.